Presentation is loading. Please wait.

Presentation is loading. Please wait.

Normal and Abnormal Growth

Similar presentations


Presentation on theme: "Normal and Abnormal Growth"— Presentation transcript:

1 Normal and Abnormal Growth
Nancy J. Charest, MD Pediatric Endocrinology Children’s Hospital at Dartmouth

2 Normal and Abnormal Growth Outline
Review the endocrine control of growth Discuss patterns of normal growth Outline clinical evaluation of growth disorders Illustrate some causes of growth failure

3 Endocrine Regulation of Growth

4 Endocrine Regulation of Growth

5 Endocrine Regulation of Growth
Growth Hormone: GRF (stimulates GH secretion) Somatostatin (inhibits GH secretion) Ghrelin (stimulates GH secretion) Insulin-like growth factors (IGF-I and IGF-II) Produced in response to growth hormone Mediates most of the effects of growth hormone Binds in serum to insulin-like growth factor binding proteins (IGFBP3) Thyroid Hormone Gonadal steroids ( estradiol and testosterone) Glucocorticoids

6 Endocrine Regulation of Growth
Hypothalamus GRF (+) Somatostatin (-) Pituitary Growth Hormone Liver, Mesenchyma Insulin Like Growth Factor 1 Bone and Cartilage

7 GH/IGF-1 AXIS Figure IGF-GH axis regulation. Growth hormone releasing factor (GHRH) and somatostatin (SMS) regulate pituitary GH secretion. GH binds to the circulating GH binding protein (GHBP), which is the cleaved extracellular domain of the GH receptor, as well as to the receptor itself. Insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) and the acid-labile subunit are produced in response to GH signal transduction. IGF mediates growth by binding to its receptor (IGF-R). In hyperinsulinemic states, serum insulin often interacts with the IGF-R and can further potentiate growth. Such growth has been observed in growth hormone deficient children who have become obese following surgery for craniopharyngioma [], [].

8 Endocrine Regulation of Growth
Thyroid hormone Skeletal growth is exquisitely sensitive to thyroid hormone Hypothyroidism impairs growth hormone release Hypothyroidism delays bone maturation and limits linear growth Hyperthyroidism accelerates linear growth and bone maturation

9 Endocrine Regulation of Growth
Gonadal steroids Estrogen and testosterone accelerate linear growth Both hormones work synergistically with growth hormone Bone maturation appears to be due to estrogen (aromatized from circulating androgens in males)

10 Normal Growth

11 Stages of Human Growth Fetal Infancy Childhood Pubertal

12 Stages of Human Growth Fetal Extraordinary growth rates (120 cm/yr!)
Not dependent on fetal pituitary (anencephalic infants are born at normal size) IGF-1 and IGF-II play a role in fetal growth Highly dependent on maternal/placental factors e.g. mult. pregnancy, placental insufficiency, maternal diabetes

13 Stages of Human Growth Infancy
Rates are initially quite high, but decelerate rapidly 40 cm/yr down to 12 cm/yr Transition towards pituitary dependent growth IGF-I, mediated by growth hormone becomes increasingly important May be a crossing of percentiles during 1st 2 yrs of life as genetic influences in stature manifest

14 Stages of Human Growth Childhood
Slowly progressive fall in growth rate from 8 cm/yr to 5 cm/yr just before puberty Children generally track along percentiles Exquisitely sensitive to growth hormone and thyroid hormone Minimal (if any) effect of sex hormones

15 Stages of Human Growth Pubertal
Rapid rise in growth rate due to sex hormones Sex hormones have direct effect on linear growth, and also increase the production of growth hormone and IGF-I

16 Growth Velocity-Girls

17

18 Growth Velocity - Boys

19

20 Evaluation of Growth

21 Key Issues for PCP in evaluating growth
Accurate height and weight Plotting of height and weight for age Growth rate Genetic height potential: mid-parental height calculation Pubertal status

22 Correct technique to measure infant

23 Inconsistent measuring technique

24 Correct technique for measuring child

25 Infant Growth Charts

26 Children Growth Charts

27 Longitudinal growth chart
Individual data obtained over time and pooled Note the sigmoid shape during puberty

28 Expected growth rates in children
Age (years) Growth rate (cm/year) 0-1 18-20 1-2 8-10 2-4 5-7 4-puberty 4-5 GROWTH RATE < 4 CM/YR SIGNALS NEED FOR EVALUATION!

29 Growth Failure-Crossing percentiles

30 Growth Failure- Growth Velocity under 4 cm/year

31 Mid-parental height (target height)
Evaluation of Growth Mid-parental height (target height) For a male, add 5 inches to mother’s height, add father’s height and divide by 2. For a female, subtract 5 inches from father’s height, add mother’s height and divide by 2. Children will normally fall within about 3.5 inches of the target height

32 Father=74 inches, Mother= 67 inches. MPH= (74+67+5)/2)=73in +/- 3
Father=74 inches, Mother= 67 inches. MPH= ( )/2)=73in +/- 3.5 in ( in)

33 Growth Failure and Short Stature
Short stature: height more than 2.0 SD below the mean for age and gender Growth failure: decline in rate of linear growth (cross channels) Short for family: (More than 3 inches below mid-parental height percentile) Growth Hormone Research Society recommends investigation of children with the above noted definitions of growth failure/short stature Referral to pediatric endocrinologist is usually indicated.

34 Evaluation of growth failure/short stature (usually performed by pediatric endocrinologist)
Bone age Laboratory testing

35 Evaluating Growth-Bone Age
Skeletal maturation (“bone age”) indirect measure of the completeness of endochondral ossification correlates with growth potential closely correlates with pubertal progression mediated by estrogens

36 6 yr M 8 yr M 10 yr M

37 Evaluating Growth Predicting adult stature based on bone age
Estimate skeletal age from radiograph Read proportion of adult height complete from tables (Greulich and Pyle) Divide current height by the proportion of growth complete

38 CA 8 yrs Bone age 8 yrs Ht. Pred. 70”

39 CA 8 yrs Bone age 6 yrs Ht prediction 74”

40 CA 8 yrs Bone age 10 yrs Ht. Prediction 67”

41 Screening labs for growth failure
IGF-1 IGF-BP3 TSH, free T4 Karyotype in female or dysmorphic child CBC with differential ESR Chemistry profile Urinalysis Celiac screen(IgA, tTG IgA Ab)

42 Growth Disorders Normal variants of growth
Endocrine causes of growth failure Non-endocrine causes of growth

43 Familial short stature
Consistent growth pattern at lower edge of height curve Parents are short Growth pattern, bone age, and puberty are appropriate for chronologic age Calculate mid-parental height or target height: Girl = {[Fa-5 in] + Mo}/2 Boy = {[Mo+5 in] + Fa}/2

44 Familial Short Stature

45 Constitutional growth delay
Family history of late onset puberty and slow growth until late adolescence Normal annual growth rate for delayed bone age Delayed puberty Predicted height in range for family No evidence of disease

46 Constitutional Delay of Growth

47 Growth Disorders Endocrine disorders that cause growth failure
Growth hormone deficiency IGF-I deficiency Hypothyroidism Hypogonadism Precocious puberty

48 Endocrine disorders that cause growth failure: Growth hormone deficiency
Decreased linear growth Hypoglycemia (in infancy) Increased adiposity (ripply abdominal fat) Bone age typically delayed Weight relatively well preserved (cherubic)

49 ER Growth Hormone Deficiency

50 Growth hormone deficiency
Figure Growth hormone (GH) deficiency occurs in approximately 1 per 10,000 children []. The severely GH-deficient child may present with hypoglycemia in the newborn period, usually indicating concomitant glucocorticoid deficiency and panhypopituitarism. After the first 6 months of life, linear growth rate slows in the GH-deficient child, resulting in downward crossing of percentiles and subsequent growth retardation. The classically GH-deficient child has a chubby appearance with increased peritruncal fat and decreased muscle mass. Skeletal age is delayed, as is pubertal development in the older child. This 5.5-year-old boy (left) with GH deficiency was significantly smaller than his fraternal twin sister (right), the discrepancy beginning in early childhood. Note his chubby immature appearance compared to that of his sibling.

51 Making the diagnosis of GH/GRF deficiency
Endocrine Disorders that cause Growth Failure: Growth Hormone Deficiency Making the diagnosis of GH/GRF deficiency Document a low growth velocity Exclude non-endocrine causes (CBC, ESR, UA, Chem panel) Exclude hypothyroidism Determine skeletal age Measure IGF-I and IGFBP-3 (low levels support the diagnosis, but are not necessarily diagnostic)

52 Because GH secretion is pulsatile, random values are not helpful.
Endocrine Disorders that cause Growth Failure: Growth Hormone Deficiency Because GH secretion is pulsatile, random values are not helpful. Most rely on provocative tests: Insulin induced hypoglycemia (“gold standard”) Arginine infusion L-Dopa, clonidine, glucagon GHRH

53 JT Growth Homone Deficiency

54 Endocrine Disorders that cause Growth Failure: Growth Hormone Deficiency
Causes Idiopathic Tumors (particularly craniopharyngioma) Radiation Genetic syndromes Defects in growth hormone gene Septo-optic dysplasia Prop-1 mutation

55 Magnetic resonance imaging of large peri-sellar mass
Figure A, Evaluation of patients presenting with a large perisellar mass. Patients with a large pituitary or perisellar mass lesion who present to medical attention, with or without symptoms, should be thoroughly investigated, because they are likely to have some hormone deficits as well as visual manifestations. A thorough general medical evaluation is very important, to address potential causes of the mass lesions as well as tolerance to possible surgical intervention. Biochemical testing of pituitary function should be performed and correlated with clinical assessment. Evaluation by a neuro-ophthalmologist, including visual field testing, is an important aspect of this process and should be done before therapeutic intervention. In most instances, an imaging study has already been done by this time. Magnetic resonance (MR) scans are the preferred choice and should be done before treatment is begun. MR scans provide a better appreciation of the anatomy and relation to surrounding structures. Furthermore, they often eliminate the need for additional neuro-imaging studies such as angiography. B and C, Two examples of perisellar mass lesions presenting for treatment. B, MRI scan of a patient with a large intrasellar mass that proved to be a craniopharyngioma (single arrow). Double arrows show the optic chiasm. C, MRI scan of a patient with optic glioma. Lesions can be easily mistaken for a pituitary adenoma.

56 Endocrine Disorders that cause Growth Failure: IGF-I deficiency
Defects in growth hormone receptor (Laron dwarfism) Low levels of growth hormone binding protein (extracellular domain of the GH receptor) High levels of growth hormone Low levels of IGFs Resistant to growth hormone treatment Responsive to IGF-I infusion

57 IGF-1 Deficiency (Laron Dwarfism)

58 Growth Disorders Hypothyroidism
Much more common than growth hormone deficiency Marked decrease in growth velocity (“crossing percentiles”) Epiphyseal fusion is delayed, preserving some growth potential Weight is well preserved or excessive Diagnosis can usually be suspected by associated signs/symptoms: cold intolerance, constipation, fatigue, bradycardia, goiter.

59 JR hypothyroidism

60 Growth Disorders Hypogonadism
Without sex hormones, the pubertal growth spurt is blunted. Because epiphyseal fusion is delayed, growth continues well past puberty There are disproportionately long arms and legs - a “eunuchoid body habitus”

61 Growth Disorders Precocious puberty
Precocious puberty results in rapid, early growth spurt There is rapid acceleration of bone age, premature fusion of growth plates, compromising adult stature

62 Non-Endocrine Causes of Growth Failure
Osteochondrodysplasias: - achondroplasia / hypochondroplasia Chromosomal disorders - Turner’s syndrome, Down’s syndrome Malabsorption Celiac disease; Inflammatory bowel disease Hypoxia Cystic fibrosis, cyanotic heart disease, anemia Iatrogenic high dose steroid treatment

63 TM Turner Syndrome

64 Turner Syndrome: 45 XO / mosaic
Short stature due to SHOX mutation Gonadal failure, female phenotype Cubitus valgus Madelung deformity of distal radius/wrist Short, webbed neck Shield chest, wide-spaced nipples, atrophic breasts Low nuccal hairline Nevi Cardiac lesions: typically aortic coarctation & hypertension Renal lesions: typically horseshoe kidney Celiac disease Autoimmune thyroid disease

65 Normal and Abnormal Growth Summary
Growth is mediated primarily through the action of IGF-I, which is stimulated by pituitary growth hormone secretion. Thyroid hormone , estrogen and testosterone interact with the GH/IGF-I axis and play important roles in human growth The timing of sex hormone secretion can have profound effects on final height, by altering the maturation of the growth plates

66 Normal and Abnormal Growth Summary
The PCP should accurately measure height and weights, plot data on growth charts, and calculate mid-parental height. PCP should know that from age 2 years until puberty, children should maintain their height along the same percentile. PCP should be able to assess growth rate in context of pubertal status.

67 Normal and Abnormal Growth Summary
Children who are: 1.more than 2 SD below the mean for height, or 2. crossing height percentiles over time or 3. short compared to parents, should be evaluated for a growth disorder by a pediatric endocrinologist.


Download ppt "Normal and Abnormal Growth"

Similar presentations


Ads by Google